Known targets — ChEMBL curated mechanism
ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol
The experimentally established mechanism targets of Hydrazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrazine SCHEMBL5543279 | 1.00 | CA2 (0.50) | — | |
| Hydroxyamine SCHEMBL5552814 | 0.90 | — | — | |
| Methylamine SCHEMBL330884 | 0.90 | — | — | |
| SCHEMBL246838 | 0.89 | CA2 (0.58) | — | |
| SCHEMBL128169 | 0.89 | — | — | |
| SCHEMBL15109974 | 0.89 | — | — | |
| SCHEMBL105 | 0.89 | — | — | |
| SCHEMBL8596055 | 0.89 | CA2 (0.58) | — | |
| SCHEMBL25599 | 0.89 | CA2 (0.58) | — | |
| Hydroxyamine SCHEMBL788269 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113614114-B | Method for quantifying oligosaccharide preparations | 帝斯曼知识产权资产管理有限公司 | 2023-08-29 | — | — | CN | disclosed |
| CN-109503418-B | Preparation process of methylhydrazine | 河北合佳医药科技集团股份有限公司 | 2021-06-08 | — | — | CN | disclosed |
| EP-0967210-B1 | PROCESS FOR PREPARING BIOLOGICALLY ACTIVE DERIVATIVES OF 1,2,4-TRIAZOL AND INTERMEDIARIES USEFUL IN THIS PROCESS | KRKA TOVARNA ZDRAVIL D D NOVO (SI) | 2003-06-04 | — | — | EP | disclosed |
| EP-0967210-A1 | PROCESS FOR PREPARING BIOLOGICALLY ACTIVE DERIVATIVES OF 1,2,4-TRIAZOL AND INTERMEDIARIES USEFUL IN THIS PROCESS | CENTRO GENESIS PARA LA INVESTIGACION, S.L. (ES) | 1999-12-29 | — | — | EP | disclosed |